Skip to content
Review Open access

TDP-43 and ALS - what's wrong with my membranes?

Oct 2026 · Neurobiology of Disease · pp. 107630 · 0 citations · 797 references
Medicine

TL;DR

Evidence suggesting that the disease Amyotrophic Lateral Sclerosis may have an early onset, potentially even prenatally, and how interactions between TDP-43 and the lipid metabolism as well as connections with membrane components, may drive cells towards ALS as time goes by are summarized.

Abstract

In recent years, multiple pathologies of the mRNA binding protein TDP-43 have been linked to the neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS), in which almost 97% of all ALS patients exhibit TDP-43 abnormalities in affected neurons. Typically, neuronal degeneration first affects alpha motor neurons of the spinal cord and the lower brainstem, before the disease progresses to Betz cells, giant neurons of the primary motor cortex, and subsequently spreads into further brain regions. It is just the Betz cells though, which do not show cytosolic TDP-43 aggregation upon loss of nuclear TDP-43 expression, but instead display membrane defects in organelles such as the Golgi apparatus, the ER and the nuclear envelope. In this review, we will therefore examine connections between TDP-43 and inner membrane systems, with a particular focus on nuclear and the ER membranes. In doing so, we will summarize evidence suggesting that the disease may have an early onset, potentially even prenatally, and describe how interactions between TDP-43 and the lipid metabolism as well as connections with membrane components, may drive cells towards ALS as time goes by.

Read PDF

Similar papers

Open access Oct 2026

Nucleoporin 50 rescues hallmarks of TDP-43 proteinopathy in ALS/FTD disease models

Nuclear depletion and cytoplasmic aggregation of RNA-binding protein TDP-43 are common neuropathological hallmarks of the amyotrophic lateral sclerosis and frontotemporal degeneration (ALS/FTD) disease spectrum. Although defects in nucleocytoplasmic transport are well-documented in ALS/FTD disease models and patient...

Courtney L. Smith, Bilal Khalil, Alyssa C. Walker et al. · 0 citations
Open access Sep 2026

TDP-43 overexpression induces cellular dysfunction and ALS-associated transcriptional changes

This stable, inducible TDP-43 overexpression model and its associated transcriptomic dataset provide a versatile platform for ALS and other TDP-43 proteinopathy research, enabling the investigation of molecular drivers of TDP-43 dysfunction, the identification of potential disease-relevant pharmacological targets, and...

Samantha A. DeSando, Kevin R. Mcclay, Amy N. Banks et al. · 0 citations
Review Open access Sep 2026

What can we learn on ALS pathophysiology from iPSC-derived motor neurons harbouring TARBDP mutations: a systematic review

The degenerating motor neurons of amyotrophic lateral sclerosis (ALS) patients are characterized by the accumulation of cytoplasmic aggregates, specifically enriched in ubiquitinated TDP-43. Expressed mainly in the nucleus and partially in the cytoplasm to execute its role in RNA metabolism, the exact mechanisms that b...

Elena Pasho, A. Catanese, E. Kabashi et al. · 0 citations

Modulating TDP-43 Protein Aggregation Directly and Indirectly in C. Elegans

Neurodegenerative diseases (NDs) are progressive disorders characterized by neuronal loss, and their prevalence is rising with an aging global population. Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease in which TDP-43 protein forms toxic aggregates in more than 95% of cases. Current FDA-approved AL...

Eman Elshaalia · 0 citations
Review Open access Aug 2026

Prion-like Protein TDP-43: Mechanisms, Diagnosis, and Therapeutic Prospects

This review synthesizes how decoding the structural and RNA-metabolic complexities of TDP-43 is paving a promising pathway from bench to bedside, while critically discussing current translational limitations.

M. Shimamura, K. Satoh · 0 citations
Open access Sep 2026

LRSAM1, an E3 ubiquitin ligase, modulates TDP-43 proteostasis in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis is a fatal neurodegenerative disease characterized by the cytoplasmic mislocalization, aberrant phosphorylation and pathological aggregation of TDP-43, a nuclear RNA-binding protein essential for RNA metabolism. Despite its central involvement in ALS pathogenesis, the molecular mechanisms...

Takayuki Shirakawa, Satsuki Mikuriya, Yuki Inoue et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.